Navigation Links
Watson Launches Generic LoSEASONIQUE(R)
Date:12/7/2011

PARSIPPANY, N.J., Dec. 7, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that under a settlement with Teva Women's Health, Watson has launched Amethia® Lo (levonorgestrel/ethinyl estradiol (0.1mg/0.02mg) and ethinyl estradiol (0.01mg)) tablets, the generic equivalent of Teva Women's Health, Inc.'s  LoSEASONIQUE®. Amethia® Lo tablets are indicated for the prevention of pregnancy.  Terms of the settlement were not disclosed.

As a "first applicant" to submit a substantially complete ANDA, Watson is eligible for 180 days of shared generic market exclusivity.  For the most recent twelve months ending September 30, 2011, LoSEASONIQUE® had sales of approximately $28 million, according to IMS Health data.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release. It is important to note that Watson's goals and expectations are not predictions of actual performance. Actual results may differ materially from Watson's current expectations depending upon a number of factors, risks and uncertainties affecting Watson's business. These factors include, among others, the
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Launches Generic LIPITOR®
2. Watson to Present at the 2011 Piper Jaffray Health Care Conference
3. Watson Wins Kentucky Drug Pricing Litigation
4. Watson Confirms Exelon(R) Patent Challenge
5. Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA
6. Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
7. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
8. Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
9. Watson Confirms Daytrana(R) Patent Challenge
10. Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
11. Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... -- Pulse Light Clinic in London,s ... as part of their ongoing research into the condition. They ... their Rosacea. The survey participants were aged between 20 and ... women. The results revealed some rather surprising statistics: ... attempt to visit their GP for Rosacea treatment. ...
(Date:6/30/2015)... 30, 2015 First Choice Wellness Care recently ... Duality and is the only clinic in the greater ... removal treatments. The practice has recently expanded their services ... to showcase their focus in the procedure. They upgraded ... faster ink clearance, and superior service. "We,ve ...
(Date:6/30/2015)... 2015  Avanir Pharmaceuticals, Inc. today announced top-line ... treatment with NUEDEXTA ® was associated with ... affect (PBA) in patients with traumatic brain injury ... characterized by sudden and uncontrollable outbursts of laughing ... brain injury. PRISM II is a phase IV ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
... 2011 Fuisz ( www.fuisz.com ) today announced the ... Permitting Stage Door Access to On-Line Vendor Information"). ... "This patent covers a system that allows a customer ... a product supplier database through the on-line vendor,s system ...
... 15, 2011 Cardium Therapeutics (NYSE Amex: ... from the Russian Ministry of Health and Social Development ... Company,s Generx™ (alferminogene tadenovec, Ad5FGF-4) biologic product candidate.  Generx ... for the potential treatment of myocardial ischemia due to ...
Cached Medicine Technology:Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 2Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 3Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 4Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 5Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 6Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 7
(Date:6/30/2015)... MD (PRWEB) , ... June 30, 2015 , ... ... offers the game’s most advanced protection at less thickness than any other padding ... company specializing in impact protection and shock absorption, Gameday Armour is engineered with ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Amerec, a ... education course offered through AEC Daily is now approved by the Interior Design ... charge through AEC Daily, provides an overview and explanation of what sauna, steam, and ...
(Date:6/30/2015)... ... June 30, 2015 , ... Isabel Healthcare announced today that it will ... for use in That Neighborhood Free Health Clinic. The Isabel diagnosis decision ... broadening differential diagnosis and expanding their perspective while working up their patients. Isabel ...
(Date:6/30/2015)... ... June 30, 2015 , ... People who want ... the aftermath of a near-death experience (NDE) – and also want to understand ... treatment options – are invited to visit https://zoom.us/webinar/register/f4a12556fe7c03f5dc2040ba88984b7b and RSVP ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... to the U.S. after a 5-day tour in India. During her stay, ... collaborating with Trivedi Master Wellness™ and Transformational Leader/Internationally Beloved Spiritual Master ...
Breaking Medicine News(10 mins):Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2Health News:Amerec’s Steam and Sauna Continuing Education Course Now Approved for Interior Design Credit 2Health News:Isabel Healthcare Donates Differential Diagnosis Decision Support Tool to That Neighborhood Foundation 2Health News:Isabel Healthcare Donates Differential Diagnosis Decision Support Tool to That Neighborhood Foundation 3Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 2Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 3Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 2Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 3
... Almost Family, Inc. (Nasdaq: AFAM ), a leading regional provider of ... Chief Financial Officer, is scheduled to present at the 27th Annual J.P. Morgan ... Event: 27th Annual J.P. Morgan ... Wednesday, January 14, 2009, Time: ...
... Christmas cookies, eggnog, juicy beef roast, rich gravy ... unfortunately can send blood cholesterol levels sky high. ... new weapon -- synthetic high-density lipoprotein (HDL), the ... high cholesterol levels and the deadly heart disease ...
... French . , Scientists from McGill ... Douglas Mental Health University Institute earn top marks in ... for their groundbreaking work. , Published in the magazine,s ... Alain Brunet, The Douglas/McGill Faculty of Medicine, Psychiatry; McGill ...
... average of 300 calories every day, study finds, , , FRIDAY, ... soda and coffee drinks have become a staple of your ... may make you drop that super-sized, sweetened beverage. , Published ... of Clinical Nutrition , the research found that people are ...
... Gynecologic Oncologists (SGO) will host its 40th Annual Meeting ... B. Gonzalez Convention Center in San Antonio, Texas. ... presentations in addition to lectures, workshops, symposia, surgical labs ... trials and treatment advances for physicians and health care ...
... Jan. 9 Pierre,s Ice Cream Company, makers ... launching another innovation,called Yovation(TM). , ... Yovation(TM) is a new premium, ... consumer interest and popularity of probiotic products and ...
Cached Medicine News:Health News:Synthetic HDL: A new weapon to fight cholesterol problems 2Health News:McGill, MUHC and Douglas researchers get top marks from Quebec Science magazine 2Health News:McGill, MUHC and Douglas researchers get top marks from Quebec Science magazine 3Health News:Americans Consuming More Sugary Beverages 2Health News:Americans Consuming More Sugary Beverages 3Health News:Society of Gynecologic Oncologists to Host 40th Annual Meeting on Women's Cancer 2Health News:Standing Ovation for Pierre's New Innovation! 2Health News:Standing Ovation for Pierre's New Innovation! 3
... D-Type can combine a number of ... microplates on a simple to use ... is a multifunctional stand-alone device but ... robotic systems. Custom and standard add-on ...
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
Smith & Nephew's CDS System is developed exclusively for discography., Developed exclusively for discography, it is the first system designed to measure true disc pressure and record real-time proce...
The Maxi-Therm® lite hyper-hypothermia water blankets from Cincinnati Sub-Zero take conductive warming and cooling therapy to a new, softer level. These blankets are soft, lightweight, and remai...
Medicine Products: